Perryman Financial Advisory’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
Perryman Financial Advisory's ABBV Position: Q2 2026 in Review
Perryman Financial Advisory reduced its AbbVie (ABBV) stake by 0.17% in Q2 2026, selling an estimated $645 and leaving 1,726 shares worth $434K. The position accounts for 0.06% of the portfolio, ranked #147.
Perryman Financial Advisory first reported a position in ABBV in Q4 2025 and has held it in 3 quarters since. 4,193 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Perryman Financial Advisory held 1,726 shares of AbbVie worth $434K as of Q2 2026.
- Perryman Financial Advisory sold 3 AbbVie shares in Q2 2026, an estimated $645.
- AbbVie made up 0.06% of Perryman Financial Advisory's portfolio in Q2 2026, its #147 holding.
- Perryman Financial Advisory first reported a position in AbbVie in Q4 2025 and has held it in 3 quarters since.
- 4,193 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Perryman Financial Advisory's 13F filing for Q2 2026, filed 24 Jul 2026.